Article info
PDFValvular heart disease
Original research article
Oral anticoagulants in atrial fibrillation with valvular heart disease and bioprosthetic heart valves
- Correspondence to Dr Aaqib H Malik, Westchester Medical Center Health Network, Valhalla, NY 10595, USA; aaqib.malik{at}wmchealth.org
Citation
Oral anticoagulants in atrial fibrillation with valvular heart disease and bioprosthetic heart valves
Publication history
- Received January 17, 2019
- Revised March 14, 2019
- Accepted March 18, 2019
- First published June 14, 2019.
Online issue publication
January 18, 2021
Article Versions
- Previous version (18 January 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.